955028-82-7 Usage
General Description
Trans-tert-butyl 4-fluoro-3-hydroxypiperidine-1-carboxylate is a chemical compound that belongs to the class of piperidine carboxylate esters. It is a derivative of piperidine with a tert-butyl group, a fluorine atom, and a hydroxyl group attached to the molecular structure. trans-tert-butyl 4-fluoro-3-hydroxypiperidine-1-carboxylate is commonly used as a building block in the synthesis of various pharmaceuticals and organic compounds. It is known for its potential use in medicinal chemistry and drug discovery due to its unique structural features. The presence of the tert-butyl and hydroxyl groups in its structure contribute to its stability and reactivity, making it valuable in the field of organic synthesis.
Check Digit Verification of cas no
The CAS Registry Mumber 955028-82-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,5,5,0,2 and 8 respectively; the second part has 2 digits, 8 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 955028-82:
(8*9)+(7*5)+(6*5)+(5*0)+(4*2)+(3*8)+(2*8)+(1*2)=187
187 % 10 = 7
So 955028-82-7 is a valid CAS Registry Number.
InChI:InChI=1/C10H18FNO3/c1-10(2,3)15-9(14)12-5-4-7(11)8(13)6-12/h7-8,13H,4-6H2,1-3H3
955028-82-7Relevant articles and documents
1 -OXO-1,2-DIHYDROISOQUINOLIN-7-YL-(5-SUBSTITUTED-THIOPHEN-2-YL)-SULFONAMIDE COMPOUNDS, FORMULATIONS CONTAINING THOSE COMPOUNDS, AND THEIR USE AS AICARFT INHIBITORS IN THE TREATMENT OF CANCERS
-
Page/Page column 31, (2016/06/28)
1-Oxo-1,2-dihydroisoquinolin-7-yl-(5-substituted-thiophen-2-yl)-sulfonamide compounds, formulations containing those compounds, and their use as AICARFT inhibitors.
DIAZEPAM DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTORS
-
Page/Page column 61, (2011/05/06)
The invention is concerned with novel bicyclic compounds of Formula (I), wherein n, m, p, A, L, R1, R2, R3, R4, R5, R6, R7, R7, R8, R9 and R10 are as defined in the description and in the claims, as well as physiologically acceptable salts thereof. These compounds are antagonists of CCR2 receptor, CCR5 receptor and/or CCR3 receptor and can be used as medicaments.
